The Chylomicronemia Syndrome Is Most Often Multifactorial A Narrative Review of Causes and Treatment

被引:93
作者
Chait, Alan [1 ,3 ]
Eckel, Robert H. [2 ,4 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[3] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, 750 Republican St,Mailstop 358062, Seattle, WA 98109 USA
[4] Univ Colorado, Anschutz Med Campus,18582 17th Ave,Mail Stop 8106, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
D O I
10.7326/M19-0203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The chylomicronemia syndrome occurs when triglyceride levels are severely elevated (usually >16.95 mmol/L [1500 mg/dL]) and is characterized by such clinical features as abdominal pain, acute pancreatitis, eruptive xanthomas, and lipemia retinalis. It may result from 1 of 3 conditions: the presence of secondary forms of hypertriglyceridemia concurrent with genetic causes of hypertriglyceridemia, termed multifactorial chylomicronemia syndrome (MFCS); a deficiency in the enzyme lipoprotein lipase and some associated proteins, termed familial chylomicronemia syndrome (FCS); or familial partial lipodystrophy. Most chylomicronemia syndrome cases are the result of MFCS; FCS is very rare. In all these conditions, triglyceride-rich lipoproteins accumulate because of impaired plasma clearance. This review describes the 3 major causes of the chylomicronemia syndrome; their consequences; and the approaches to treatment, which differ considerably by group.
引用
收藏
页码:626 / +
页数:10
相关论文
共 91 条
[1]  
[Anonymous], NAT GENET
[2]  
Aryal Madan Raj, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-008550
[3]   GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins [J].
Beigneux, Anne P. ;
Davies, Brandon S. J. ;
Bensadoun, Andre ;
Fong, Loren G. ;
Young, Stephen G. .
JOURNAL OF LIPID RESEARCH, 2009, 50 :S57-S62
[4]   Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene [J].
Benlian, P ;
DeGennes, JL ;
Foubert, L ;
Zhang, HF ;
Gagne, SE ;
Hayden, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :848-854
[5]  
Brunzell J D, 1986, Adv Exp Med Biol, V201, P227
[6]  
Brunzell J.D., 1989, Metabolic Basis of Inherited Disease, P1165
[7]  
Brunzell JD., 2001, METABOLIC MOL BASES, V8th, P2789
[8]   Treatment of hypertriglyceridemia [J].
Capell W.H. ;
Eckel R.H. .
Current Diabetes Reports, 2006, 6 (3) :230-240
[9]   CHYLOMICRONEMIA SYNDROME IN DIABETES-MELLITUS [J].
CHAIT, A ;
ROBERTSON, HT ;
BRUNZELL, JD .
DIABETES CARE, 1981, 4 (03) :343-348
[10]  
Chait A, 2019, ENDOTEXT